Literature DB >> 25542054

Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.

Ángel Asensio1, Mireia Cantero1, Evelyn Shaw2, Salvador Vergara-López3.   

Abstract

There has been a rapid increase in recent years in the incidence of infection and colonization by carbapenemase-producing Enterobacteriaceae (CPE). A number of clusters and outbreaks have been reported, some of which have been contained, providing evidence that these clusters and outbreaks can be managed effectively when the appropriate control measures are implemented. This review outlines strategies recommended to control CPE dissemination both at the healthcare facility level (acute and long-term care) and from the public health point of view. A dedicated prepared plan should be required to prevent the spread of CPE at the hospital level. At the front line, activities should include management of patients at admission and new cases, active surveillance culturing and definition of high-risk groups. High compliance with standard precautions for all patients and full or modified contact precautions for defined categories of patients should be implemented. Long-term care facilities are areas where dissemination can also take place but more importantly they can become a reservoir as patients are admitted and released to other Health care facilities. From the public health point of view, surveillance must be tailored to identify regional spread and interfacility transmission to prevent further dissemination. Finally, a comprehensive set of activities at various levels is necessary to prevent further spread of these bacteria in the community.
Copyright © 2014 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Carbapenemase-producing Enterobacteriaceae; Control de la infección; Enterobacterias productoras de carbapenemasas; Healthcare facilities; Hospital preparation plan; Infection control; Instituciones de crónicos; Instituciones sanitarias; Long-term care facilities; Plan de preparación para el hospital

Mesh:

Substances:

Year:  2014        PMID: 25542054     DOI: 10.1016/S0213-005X(14)70176-4

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  3 in total

1.  The use of multi-pronged screening strategy to understand the epidemiology of carbapenemase-producing Enterobacteriaceae in Hong Kong: transition from epidemic to endemic setting.

Authors:  Shuk- Ching Wong; Veronica Wing- Man Chan; Germaine Kit-Ming Lam; Christine Ho-Yan AuYeung; Elaine Yin-Ling Leung; Simon Yung-Chun So; Jonathan Hon-Kwan Chen; Siddharth Sridhar; Anthony Raymond Tam; Ivan Fan-Ngai Hung; Pak- Leung Ho; Kwok- Yung Yuen; Vincent Chi-Chung Cheng
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-03-05       Impact factor: 3.267

2.  Active surveillance of carbapenem-resistant gram-negative bacteria to guide antibiotic therapy: a single-center prospective observational study.

Authors:  Qiqiang Liang; Juan Chen; Yongshan Xu; Yibing Chen; Man Huang
Journal:  Antimicrob Resist Infect Control       Date:  2022-06-22       Impact factor: 6.454

3.  [Risk factors and clinical evolution of carbapenemase-producing Klebsiella pneumoniae infections in a university hospital in Spain. Case-control study].

Authors:  V Rojo; P Vázquez; S Reyes; L Puente Fuertes; M Cervero
Journal:  Rev Esp Quimioter       Date:  2018-09-18       Impact factor: 1.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.